

Care for a growing number of Connecticut residents is being directed by an Accountable Care Organization (ACO) and very few patients know it.
ACOs are large health systems of providers that have arrangements with insurers and government payers to lower the cost of your care. ACO networks can include a hospital, primary-care and specialty-care providers as well as other professionals and facilities.
In their best form, ACOs allow providers to work together, share patient information and assess members’ health needs. ACOs can ensure that patients get the care they need, and only the care they need, to stay healthy. But they can also reduce necessary care, avoid expensive patients, and end up costing us more.
Unfortunately, no one is watching.
If you think ACOs sound like the failed, old HMO model, you’re not alone. And ACOs are growing. Estimates place Connecticut ACO enrollment at 15% to 20%, among the highest rates in the nation. There are currently 14 Medicare and Medicaid ACOs, each covering over 300,000 Connecticut residents. There is no public reporting on ACOs covering privately-insured people in Connecticut.
As ACOs grow, so do concerns. To control costs, ACOs are generally reimbursed half the savings that they are able to generate on their patients’ care. ACOs only receive savings payments if they achieve a few quality metrics, but those are generally set very low and have little to do with health outcomes.
As with HMOs, this can lead to denials of necessary care and shifting away difficult or less lucrative patients. It is already happening in other states.
Rather than saving money, there are concerns that ACOs could increase costs. As ACOs increase consolidation in Connecticut’s already concentrated health care market, consumers will have fewer choices for their care and prices will rise. In 2016, Connecticut’s Medicare ACOs overspent by $45 million. Medicaid ACOs cost Connecticut taxpayers millions in their first year with no discernible improvement in quality.
We really know very little about how ACOs are treating Connecticut patients or how much money they are saving or costing us. Connecticut does not monitor or regulate ACOs. Since 1895, Connecticut has regulated insurance companies that take on financial risk, as it does with HMOs. ACOs take on financial risk, but today are not regulated here.
It’s not that ACOs aren’t regulated anywhere: Massachusetts has a certification program for ACOs and Vermont, with a small population, has created a statewide all-payer ACO.
Both Massachusetts and Vermont have long histories of protecting consumers and taxpayers with data-based policymaking, collaborative health reforms and trusted oversight. NCQA, a non-government independent leader in accreditation standards, certifies ACOs to complement care transformation and payment reforms.
Support authentic, locally owned and operated public service journalism!
As ACO enrollment grows and they exert more control over the care Connecticut residents receive and pay for, it is imperative that the state monitor their impact on our health, our costs, our taxes, and our care.
Ellen Andrews, PhD, is the executive director of the CT Health Policy Project. Follow her on Twitter @CTHealthNotes.
DISCLAIMER: The views, opinions, positions, or strategies expressed by the author are theirs alone, and do not necessarily reflect the views, opinions, or positions of CTNewsJunkie.com.
More Health Care News & Analysis
Medical Examining Board Fines Doctor $10,000
The state Medical Examining Board on Tuesday fined an Oxford doctor $10,000 for fraudulently using another doctor’s name and Drug Enforcement Agency registration number to prescribe controlled substances to a family member.
Keep reading
Clinical Trials With Immunotherapy Drugs Are Source Of Hope And Challenges In Treating Aggressive Breast Cancer
Joshalyn Mills of Branford and Nancy Witz of Kensington had the best possible results after being treated in clinical trials with immunotherapy drugs for aggressive breast cancer: Their tumors were eliminated. But while there are dramatic successes with immunotherapy drugs, there are also many failures, and researchers are trying to find out why in hopes…
Keep reading
Coalition of Health Insurers Questions Viability of Connecticut Partnership Plan
Members of Connecticut’s Health Care Future, a coalition of health insurers, hospitals, and businesses, are questioning whether Connecticut lawmakers have done enough this year to protect teachers and municipal employees from increases in health insurance premiums. “Despite repeated bailouts from taxpayers, the Connecticut Partnership Plan continues to be a fiscal Titanic that demonstrates why government-controlled health…
Keep reading
AG’s Tackle Mental Health Parity
Attorneys General in Connecticut and Rhode Island threw their support Monday behind a coalition of mental health advocacy groups asking a federal appeals court to revisit a recent ruling giving insurance companies more flexibility to deny mental health claims.
Keep reading
Budget Green Lights Psychedelic Therapies
Buried in the budget Gov. Ned Lamont signed this week is a provision that would create a pilot program to allow Connecticut to be the first-in-the-nation to study the impact of psychedelic drugs like psilocybin and MDMA on patients with depression and PTSD. The budget now creates a pilot program within the Department of Mental…
Keep reading
Officials Highlight Effort To Boost Mental Health Services For Kids
At a Hartford-based community provider Wednesday, Gov. Ned Lamont and a handful of his agency commissioners highlighted the expected impact of more than $100 million in recently passed funding aimed at increasing behavioral health services for Connecticut children. The governor appeared at The Village for Families and Children, a recipient of new state funding included…
Keep reading